Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Nitsch

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
The Journal of Biological Chemistry|November 5, 1993
Activation of protein kinase C inhibits cellular production of the amyloid beta-proteinA Y Hung, C Haass, R M Nitsch, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 20, 1998
Increased blood mercury levels in patients with Alzheimer's diseaseC Hock, G Drasch, S Golombowski, et al.
Neurogenetics|August 5, 2003
Association of late-onset Alzheimer disease with a genotype of PLAU, the gene encoding urokinase-type plasminogen activator on chromosome 10q22.2U Finckh, K van Hadeln, T Müller-Thomsen, et al.
American Journal of Human Genetics|January 13, 2000
High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genesU Finckh, T Müller-Thomsen, U Mann, et al.
Molecular Psychiatry|July 20, 2016
Genetic ablation of the p66<sup>Shc</sup> adaptor protein reverses cognitive deficits and improves mitochondrial function in an APP transgenic mouse model of Alzheimer's diseaseR Derungs, G G Camici, R D Spescha, et al.
Annals of the New York Academy of Sciences|September 24, 1993
Receptor-coupled amyloid precursor protein processingR M Nitsch, B E Slack, S A Farber, et al.
Annals of the New York Academy of Sciences|February 24, 2001
High frequency of mutations in four different disease genes in early-onset dementiaU Finckh, T Müller-Thomsen, U Mann, et al.
Annals of the New York Academy of Sciences|February 24, 2001
Treatment with the selective muscarinic agonist talsaclidine decreases cerebrospinal fluid levels of total amyloid beta-peptide in patients with Alzheimer's diseaseC Hock, A Maddalena, I Heuser, et al.
Molecular Psychiatry|July 10, 2003
Genetic association of acyl-coenzyme A: cholesterol acyltransferase with cerebrospinal fluid cholesterol levels, brain amyloid load, and risk for Alzheimer's diseaseM A Wollmer, J R Streffer, M Tsolaki, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 18, 2003
Saitohin gene is not associated with Alzheimer's diseaseJ R Streffer, A Papassotiropoulos, P Kurosinski, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Biological Chemistry|November 5, 1993
Activation of protein kinase C inhibits cellular production of the amyloid beta-proteinA Y Hung, C Haass, R M Nitsch, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 20, 1998
Increased blood mercury levels in patients with Alzheimer's diseaseC Hock, G Drasch, S Golombowski, et al.
Neurogenetics|August 5, 2003
Association of late-onset Alzheimer disease with a genotype of PLAU, the gene encoding urokinase-type plasminogen activator on chromosome 10q22.2U Finckh, K van Hadeln, T Müller-Thomsen, et al.
American Journal of Human Genetics|January 13, 2000
High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genesU Finckh, T Müller-Thomsen, U Mann, et al.
Molecular Psychiatry|July 20, 2016
Genetic ablation of the p66<sup>Shc</sup> adaptor protein reverses cognitive deficits and improves mitochondrial function in an APP transgenic mouse model of Alzheimer's diseaseR Derungs, G G Camici, R D Spescha, et al.
Annals of the New York Academy of Sciences|September 24, 1993
Receptor-coupled amyloid precursor protein processingR M Nitsch, B E Slack, S A Farber, et al.
Annals of the New York Academy of Sciences|February 24, 2001
High frequency of mutations in four different disease genes in early-onset dementiaU Finckh, T Müller-Thomsen, U Mann, et al.
Annals of the New York Academy of Sciences|February 24, 2001
Treatment with the selective muscarinic agonist talsaclidine decreases cerebrospinal fluid levels of total amyloid beta-peptide in patients with Alzheimer's diseaseC Hock, A Maddalena, I Heuser, et al.
Molecular Psychiatry|July 10, 2003
Genetic association of acyl-coenzyme A: cholesterol acyltransferase with cerebrospinal fluid cholesterol levels, brain amyloid load, and risk for Alzheimer's diseaseM A Wollmer, J R Streffer, M Tsolaki, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 18, 2003
Saitohin gene is not associated with Alzheimer's diseaseJ R Streffer, A Papassotiropoulos, P Kurosinski, et al.
Pageof 9